Trazodone A Look at its Therapeutic Actions Patient Safety and Proper Dosing

Trazodone, with its active ingredient trazodone hydrochloride, is a widely recognized medication primarily used in the management of major depressive disorder. Its unique pharmacological profile, however, also makes it a valuable tool in addressing insomnia, particularly when sleep disturbances accompany depressive symptoms or are a standalone concern. As a serotonin antagonist and reuptake inhibitor (SARI), Trazodone offers a distinct approach to balancing brain chemistry, contributing significantly to improved mood and sleep quality for countless individuals across the United States and Canada.

This comprehensive guide aims to provide detailed information about Trazodone, covering its mechanism of action, approved uses, dosage guidelines, potential side effects, and important precautions. Our goal is to empower consumers with the knowledge needed to understand this medication better, helping them make informed decisions in consultation with their healthcare providers. It is important to remember that all medical information should be discussed with a qualified health professional.

What is Trazodone?

Trazodone is an antidepressant medication belonging to the phenylpiperazine class, specifically categorized as a serotonin antagonist and reuptake inhibitor (SARI). Its active compound, trazodone hydrochloride, operates on specific neurotransmitter systems in the brain to produce its therapeutic effects. Unlike some other classes of antidepressants, Trazodone has a distinctive mechanism that provides both antidepressant and significant sedative properties, making it versatile for treating different aspects of mental health conditions.

Primarily, Trazodone is prescribed for the treatment of major depressive disorder. In this context, it works to alleviate the persistent feelings of sadness, loss of interest, fatigue, and other debilitating symptoms associated with clinical depression. Beyond its antidepressant actions, the sedative effects of Trazodone have led to its widespread off-label, but medically accepted, use as a treatment for insomnia. This is particularly beneficial for individuals who experience difficulty falling or staying asleep, especially if their insomnia is linked to anxiety or depression.

The availability of Trazodone in various oral tablet strengths allows healthcare providers to tailor treatment to individual patient needs, optimizing efficacy while minimizing potential side effects. Its role in modern medicine underscores its importance in offering relief for those struggling with the intertwined challenges of mood disorders and sleep disturbances.

Approved Uses of Trazodone

Treatment of Major Depressive Disorder

Trazodone is officially approved for the treatment of major depressive disorder (MDD). MDD is a serious medical illness characterized by a persistent sad mood, loss of interest in activities once enjoyed, changes in appetite or sleep patterns, fatigue, feelings of worthlessness or guilt, difficulty concentrating, and thoughts of death or suicide. Trazodone hydrochloride helps to rebalance certain natural chemicals (neurotransmitters) in the brain, particularly serotonin, which are believed to play a crucial role in mood regulation.

When used for depression, Trazodone is typically initiated at a lower dose and gradually increased over several weeks under medical supervision. This gradual titration helps the body adjust to the medication and minimizes the risk of side effects. Patients often experience an improvement in depressive symptoms, including mood, energy levels, and overall outlook on life, as the medication reaches its full therapeutic effect. It’s important to understand that the antidepressant effects of Trazodone may take several weeks to become fully apparent, and consistent adherence to the prescribed regimen is vital for successful treatment outcomes.

Management of Insomnia

While Trazodone is primarily an antidepressant, its potent sedative properties have led to its widespread and recognized off-label use for the treatment of insomnia. This is especially true for individuals who struggle with sleep difficulties, whether they are experiencing depression concurrently or have insomnia as a primary concern. Many healthcare professionals in the US and Canada prescribe Trazodone at lower doses than those used for depression to help patients fall asleep faster, stay asleep longer, and improve the overall quality of their sleep.

The use of Trazodone for insomnia is supported by its ability to block certain serotonin receptors in the brain that are associated with wakefulness, while also weakly inhibiting serotonin reuptake, contributing to its calming effects. It can be particularly beneficial for those whose insomnia is exacerbated by anxiety or other conditions that disrupt sleep architecture. For these patients, Trazodone offers an alternative to traditional hypnotics, often with a different side effect profile. Patients often report feeling more rested and experiencing fewer nocturnal awakenings, leading to improved daytime functioning and quality of life.

Other Medically Accepted Uses

In addition to its primary indications, Trazodone may be considered by healthcare professionals for other specific situations, always based on careful clinical judgment and patient needs. Its anxiolytic (anxiety-reducing) properties can be beneficial for individuals experiencing significant anxiety, particularly when it contributes to their insomnia or is comorbid with depression. While not a first-line treatment for anxiety disorders, its sedative effects can provide relief in certain circumstances.

Furthermore, in some cases, Trazodone may be used as an adjunct therapy in complex psychiatric regimens to address specific symptoms that other medications may not fully control, such as severe agitation or sleep disturbances in patients with various mood or anxiety disorders. These applications are typically reserved for situations where a thorough assessment by a healthcare provider deems Trazodone to be a suitable and beneficial option, always weighing the potential benefits against any risks for the individual patient.

How Trazodone Works: Mechanism of Action

Trazodone hydrochloride exerts its therapeutic effects through a complex interaction with various neurotransmitter systems in the brain. Its primary classification as a serotonin antagonist and reuptake inhibitor (SARI) accurately describes its dual mechanism of action, which differentiates it from other antidepressant classes like selective serotonin reuptake inhibitors (SSRIs).

Firstly, Trazodone acts as a weak inhibitor of serotonin reuptake. By blocking the reabsorption of serotonin back into nerve cells, it increases the concentration of serotonin in the synaptic cleft, the space between neurons. This enhanced availability of serotonin is believed to contribute to its antidepressant effects over time, as serotonin is a crucial neurotransmitter involved in mood regulation, emotions, and overall well-being.

Secondly, and perhaps more significantly for its acute effects, Trazodone is a potent antagonist at specific serotonin receptors, particularly the 5-HT2A and 5-HT2C receptors. By blocking these receptors, Trazodone not only prevents serotonin from binding to them but also indirectly enhances serotonin’s activity at other beneficial receptors (like 5-HT1A), which are associated with antidepressant and anxiolytic effects. The blockade of 5-HT2A receptors is strongly implicated in Trazodone‘s sedative and anxiolytic properties, making it effective for insomnia and anxiety reduction.

Additionally, Trazodone exhibits antagonistic effects at alpha-1 adrenergic receptors and histamine H1 receptors. The blockade of alpha-1 adrenergic receptors can contribute to its sedative effects and may also be responsible for some of its cardiovascular side effects, such as orthostatic hypotension (a sudden drop in blood pressure upon standing). The blockade of H1 receptors also contributes to its sedative and sometimes anticholinergic side effects (like dry mouth).

The combination of these actions – weak serotonin reuptake inhibition, potent serotonin receptor antagonism, and other receptor interactions – allows Trazodone to modulate brain activity in a way that alleviates symptoms of depression and promotes sleep, making it a multifaceted medication in mental health care.

Dosage and Administration

The dosage of Trazodone can vary significantly depending on the condition being treated and the individual patient’s response. It is crucial to always follow the specific instructions provided by your healthcare provider. Never adjust your dose or stop taking the medication without consulting a medical professional.

For the treatment of major depressive disorder, the starting dose of Trazodone is typically lower, often around 150 mg per day, divided into two or three doses. This dose may be gradually increased by the healthcare provider, usually in increments of 50 mg to 100 mg per day every 3 to 7 days, up to a maximum recommended dose, which can range from 400 mg to 600 mg per day in divided doses for outpatients, and even higher for hospitalized patients. The full antidepressant effect may take several weeks to manifest, so patience and consistent adherence are important.

When used for insomnia, Trazodone is generally prescribed at much lower doses due to its potent sedative effects. Common dosages for insomnia range from 25 mg to 100 mg, typically taken once daily at bedtime. The lower doses for insomnia aim to utilize the drug’s sedative properties without necessarily achieving the full antidepressant effect. Patients should take Trazodone on an empty stomach to enhance absorption for insomnia treatment, but with food when prescribed for depression to help reduce nausea and dizziness.

It is generally recommended to take Trazodone with a meal or a light snack, especially when taking higher doses for depression, as this can help minimize gastrointestinal upset and enhance absorption. Taking it at bedtime, particularly for insomnia or when sedation is a desired effect for depression, is common due to its drowsiness-inducing properties. Always consult your healthcare provider for precise dosing instructions tailored to your specific medical needs and health profile.

Potential Side Effects

Like all medications, Trazodone can cause side effects, although not everyone experiences them. The severity and incidence of side effects can vary depending on the dosage, individual sensitivity, and the duration of treatment. It is important to discuss any concerns or adverse reactions with your healthcare provider.

Common Side Effects:

• Drowsiness or Sedation: This is a very common side effect, especially at higher doses or when first starting the medication. It’s often utilized when Trazodone is prescribed for insomnia.
• Dizziness or Lightheadedness: Can occur due to Trazodone‘s effect on blood pressure, especially when standing up quickly (orthostatic hypotension).
• Nausea, Vomiting, or Diarrhea: Gastrointestinal upset is common, particularly when taking the medication on an empty stomach.
• Dry Mouth: A frequent anticholinergic side effect.
• Blurred Vision: Another potential anticholinergic effect.
• Headache: Can occur in some individuals.
• Fatigue: A general feeling of tiredness.
• Constipation: Less common but can occur.

Less Common but More Serious Side Effects:

• Orthostatic Hypotension: A significant drop in blood pressure upon standing, which can lead to fainting. This risk is higher in elderly patients or those with cardiovascular conditions.
• Cardiac Arrhythmias: Although rare, Trazodone can affect heart rhythm, especially in individuals with pre-existing heart conditions.
• Priapism: A prolonged, painful erection that is not related to sexual activity. This is a rare but serious side effect that requires immediate medical attention, as it can lead to permanent damage if not treated promptly.
• Serotonin Syndrome: A potentially life-threatening condition that can occur if Trazodone is taken with other serotonergic drugs (e.g., SSRIs, SNRIs, MAOIs, triptans). Symptoms include agitation, hallucinations, rapid heart rate, fever, sweating, muscle rigidity, and severe nausea/vomiting/diarrhea.
• Increased Risk of Suicidal Thoughts or Behavior: Antidepressants, including Trazodone, may increase the risk of suicidal thoughts or behavior in children, adolescents, and young adults (up to 24 years of age) with major depressive disorder or other psychiatric disorders, especially during the initial stages of treatment or when the dose is changed. Patients of all ages should be closely monitored for changes in behavior, agitation, or worsening of depression.
• Abnormal Bleeding: Trazodone may increase the risk of bleeding or bruising, especially when taken with other medications that affect blood clotting (e.g., NSAIDs, warfarin).
• Hyponatremia: Low sodium levels in the blood, particularly in elderly patients or those taking diuretics.
• Liver Problems: Rarely, Trazodone can cause liver enzyme elevations or more serious liver injury.

It is important to promptly report any new or worsening symptoms, particularly severe dizziness, chest pain, irregular heartbeat, prolonged erection, or any signs of allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing) to your healthcare provider.

Drug Interactions

Interactions between Trazodone and other medications, supplements, or even certain foods can alter its effects or increase the risk of side effects. It is critical to inform your healthcare provider about all prescription and non-prescription drugs, herbal products, and supplements you are currently taking before starting Trazodone.

Key Drug Interactions:

• Monoamine Oxidase Inhibitors (MAOIs): Concomitant use of Trazodone with MAOIs (e.g., phenelzine, tranylcypromine) or within 14 days of stopping an MAOI is contraindicated due to the risk of serotonin syndrome, a potentially fatal reaction.
• Other Serotonergic Drugs: Taking Trazodone with other medications that increase serotonin levels, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), triptans (for migraines), linezolid, fentanyl, lithium, tramadol, St. John’s Wort, or other antidepressants, can increase the risk of serotonin syndrome.
• Central Nervous System (CNS) Depressants: Concurrent use of Trazodone with alcohol, benzodiazepines (e.g., alprazolam, diazepam), other sedatives, hypnotics, or opioid pain medications can significantly enhance CNS depression, leading to increased drowsiness, dizziness, and impaired coordination.
• Anticoagulants (Blood Thinners): Trazodone may increase the risk of bleeding when taken with anticoagulants like warfarin, or with antiplatelet drugs such as aspirin and NSAIDs (e.g., ibuprofen, naproxen). Close monitoring of blood clotting parameters may be necessary.
• Drugs that Prolong the QT Interval: Trazodone can, in rare cases, prolong the QT interval on an electrocardiogram (ECG). Using it with other medications that also prolong the QT interval (e.g., certain antiarrhythmics, antipsychotics, antibiotics) can increase the risk of serious heart rhythm abnormalities.
• CYP3A4 Inhibitors: Medications that inhibit the CYP3A4 enzyme (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir, indinavir) can increase Trazodone levels in the blood, potentially leading to increased side effects. A lower Trazodone dose may be required.
• CYP3A4 Inducers: Drugs that induce the CYP3A4 enzyme (e.g., carbamazepine, phenytoin, rifampin) can decrease Trazodone levels, potentially reducing its effectiveness. A higher Trazodone dose might be needed.
• Digoxin and Phenytoin: Trazodone may increase the blood levels of digoxin and phenytoin. Monitoring of these drug levels may be advised.

This is not an exhaustive list. Always consult your healthcare provider or pharmacist for a complete list of potential interactions, as individual circumstances can vary. Never start or stop any medication without professional medical advice.

Warnings and Precautions

When taking Trazodone, certain warnings and precautions are important to ensure its safe and effective use. Adhering to these guidelines and maintaining open communication with your healthcare provider are crucial for optimizing treatment outcomes and minimizing risks.

• Abrupt Discontinuation: Do not abruptly stop taking Trazodone. Suddenly discontinuing the medication, especially after prolonged use, can lead to withdrawal symptoms such as anxiety, agitation, insomnia, headache, and nausea. Your healthcare provider will guide you on how to gradually reduce your dose when it’s time to stop the medication.
• Suicidal Thoughts and Behaviors: Antidepressants, including Trazodone, may increase the risk of suicidal thoughts or behavior in children, adolescents, and young adults (generally up to 24 years of age) compared to placebo. This risk is particularly noted during the initial stages of treatment or when dosages are adjusted. Patients of all ages should be closely monitored for any changes in behavior, worsening depression, agitation, or the emergence of suicidal ideation. Families and caregivers should also be vigilant for these changes and report them immediately to a healthcare provider.
• Sedation and Impaired Abilities: Trazodone can cause significant drowsiness, dizziness, and blurred vision. These effects can impair your ability to drive, operate machinery, or perform other tasks requiring alertness. It is essential to understand how Trazodone affects you before engaging in such activities. Avoid consuming alcohol or other CNS depressants, as these can exacerbate the sedative effects.
• Cardiovascular Disease: Use Trazodone with caution in patients with pre-existing cardiac conditions, such as heart disease, arrhythmias, or recent myocardial infarction. Trazodone has been associated with orthostatic hypotension (a drop in blood pressure upon standing) and, rarely, cardiac arrhythmias.
• Priapism: As mentioned, priapism (a prolonged, painful erection) is a rare but serious side effect of Trazodone. Patients should be advised to seek immediate medical attention if this occurs to prevent potential permanent damage.
• Angle-Closure Glaucoma: Antidepressants like Trazodone can sometimes cause pupil dilation, which might trigger an angle-closure attack in patients with anatomically narrow angles that have not undergone iridectomy. Patients with a history of angle-closure glaucoma should use Trazodone with caution.
• Hypotension: Patients with a history of orthostatic hypotension or those predisposed to it should be carefully monitored, especially during the initial dosing period.
• Hepatic and Renal Impairment: Patients with significant liver or kidney dysfunction may require dose adjustments, as these organs are responsible for metabolizing and eliminating Trazodone from the body.
• Serotonin Syndrome: Be vigilant for symptoms of serotonin syndrome, especially when Trazodone is used with other serotonergic agents. Prompt medical attention is required if symptoms such as agitation, hallucinations, rapid heart rate, muscle rigidity, and fever develop.

Always communicate your full medical history and all current medications with your healthcare provider to ensure Trazodone is safe and appropriate for your specific health situation.

Special Considerations

Certain patient populations require particular attention and careful consideration when prescribing and administering Trazodone due to unique physiological factors or potential risks.

Pregnancy and Lactation:

The use of Trazodone during pregnancy should be approached with caution. There is limited data on its safety in pregnant women. Animal studies have shown some adverse effects, but human data is insufficient to establish a clear risk. If you are pregnant, planning to become pregnant, or become pregnant while taking Trazodone, it is crucial to discuss the potential risks and benefits with your healthcare provider. Untreated depression can also pose risks to both the mother and the fetus, so the decision to continue or discontinue medication should be made on a case-by-case basis after careful evaluation of the individual circumstances.

Trazodone is known to be excreted in human breast milk. Due to the potential for adverse effects in nursing infants (e.g., sedation), a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Close monitoring of the infant for signs of drowsiness or poor feeding is recommended if breastfeeding continues while the mother is taking Trazodone.

Geriatric Use:

Elderly patients (65 years and older) may be more sensitive to the effects of Trazodone, particularly its sedative and hypotensive (blood pressure-lowering) effects. They may also be at an increased risk of orthostatic hypotension, dizziness, and falls. Therefore, lower starting doses and slower dose titration are often recommended for geriatric patients. Close monitoring for adverse effects is essential in this population. Additionally, elderly patients may be more susceptible to hyponatremia (low sodium levels in the blood) when taking antidepressants.

Pediatric Use:

The safety and efficacy of Trazodone in pediatric patients (under 18 years of age) have not been fully established for major depressive disorder. While some healthcare providers may prescribe it off-label for insomnia or other conditions in children, this is typically done with extreme caution and based on individual clinical judgment. As with other antidepressants, there is an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults up to 24 years of age when taking Trazodone for depression or other psychiatric indications. Close monitoring by a healthcare provider is essential if Trazodone is used in this age group.

Patients with Bipolar Disorder:

As an antidepressant, Trazodone carries the risk of precipitating a manic or hypomanic episode in patients with undiagnosed or known bipolar disorder. It is important to screen patients for a history of bipolar disorder before initiating antidepressant treatment. If a patient experiences symptoms of mania or hypomania (e.g., elevated mood, increased energy, decreased need for sleep, racing thoughts) while on Trazodone, the medication should be discontinued, and the treatment plan should be reassessed.

These special considerations highlight the importance of personalized medicine and thorough patient assessment to ensure that Trazodone is prescribed and used appropriately, maximizing its benefits while minimizing potential risks.

Characteristics of Trazodone

Characteristic	Description
Active Ingredient	Trazodone hydrochloride
Drug Class	Serotonin Antagonist and Reuptake Inhibitor (SARI)
Primary Indications	Major Depressive Disorder, Insomnia
Mechanism of Action	Modulates serotonin neurotransmission by inhibiting reuptake and blocking specific receptors (5-HT2A, 5-HT2C), and antagonizing alpha-1 adrenergic and H1 histamine receptors.
Typical Dosing (General)	Varies significantly by indication: lower doses for insomnia (e.g., 25-100 mg at bedtime), higher doses for depression (e.g., 150-600 mg daily in divided doses). Always individualized by physician.
Common Side Effects	Drowsiness, dizziness, nausea, dry mouth, headache, blurred vision, constipation.
Serious Side Effects (Rare)	Orthostatic hypotension, priapism, serotonin syndrome, cardiac arrhythmias, increased risk of suicidal thoughts (in young adults).
Forms Available	Oral tablets (various strengths).
Onset of Action (Sedation)	Relatively rapid, typically within 30-60 minutes after taking a dose.
Onset of Action (Antidepressant Effects)	May take several weeks (typically 2-4 weeks or longer) for full antidepressant benefits to be realized.
Metabolism	Primarily metabolized in the liver by the CYP3A4 enzyme.
Elimination	Excreted mainly through urine and feces.

Frequently Asked Questions About Trazodone

Here are some of the most common questions individuals have about Trazodone, along with detailed answers to provide further clarity.

Q: How long does Trazodone take to work for insomnia?

A: For insomnia, Trazodone typically starts to work relatively quickly. Many individuals experience its sedative effects within 30 to 60 minutes after taking a dose. This rapid onset makes it effective for helping people fall asleep. However, the full benefit of improved sleep quality and reduced nighttime awakenings might become more noticeable over a few nights of consistent use.

Q: How long does Trazodone take to work for depression?

A: When used for major depressive disorder, the antidepressant effects of Trazodone do not typically appear immediately. It generally takes several weeks to notice a significant improvement in mood and other depressive symptoms. Patients may start to feel some benefits within 2 to 4 weeks, but the full therapeutic effect often requires 6 to 8 weeks or even longer of consistent treatment. It’s crucial to continue taking the medication as prescribed, even if you don’t feel immediate relief, and to communicate any concerns with your healthcare provider.

Q: Can I stop taking Trazodone suddenly?

A: No, you should not stop taking Trazodone suddenly, especially if you have been on it for an extended period or at higher doses. Abrupt discontinuation can lead to withdrawal symptoms, which may include anxiety, agitation, insomnia, headache, nausea, and dizziness. Your healthcare provider will guide you through a gradual tapering process to safely reduce your dose over time, minimizing the risk of these uncomfortable symptoms. Always consult your doctor before making any changes to your medication regimen.

Q: Is Trazodone addictive?

A: Trazodone is generally not considered to be addictive in the same way as controlled substances like benzodiazepines or opioids. It does not typically cause drug-seeking behavior or tolerance that would lead to increasing doses for recreational purposes. However, as noted, discontinuing Trazodone suddenly can lead to withdrawal-like symptoms, which is a common characteristic of many antidepressants. This “discontinuation syndrome” is distinct from addiction.

Q: Can Trazodone be taken with alcohol?

A: It is strongly advised to avoid consuming alcohol while taking Trazodone. Both Trazodone and alcohol are central nervous system (CNS) depressants. Combining them can significantly increase the sedative effects, leading to excessive drowsiness, dizziness, impaired coordination, and potentially dangerous levels of sedation. This can severely impair your ability to drive or perform other activities requiring alertness and may increase the risk of accidents.

Q: What are the most common side effects of Trazodone?

A: The most common side effects of Trazodone include drowsiness (which is often a desired effect for insomnia), dizziness, lightheadedness, nausea, dry mouth, headache, and blurred vision. These side effects are often mild and may decrease as your body adjusts to the medication. Taking Trazodone with food, especially for higher doses, can help reduce gastrointestinal upset. If any side effects are persistent or bothersome, discuss them with your healthcare provider.

Q: Can Trazodone affect my blood pressure?

A: Yes, Trazodone can affect blood pressure, particularly by causing orthostatic hypotension. This is a sudden drop in blood pressure that occurs when you stand up quickly from a sitting or lying position, which can lead to dizziness, lightheadedness, or even fainting. This effect is more common at the beginning of treatment or with dose increases. It is advisable to stand up slowly and avoid sudden movements, especially if you feel dizzy. Patients with pre-existing heart conditions or low blood pressure should use Trazodone with caution and be monitored by their doctor.

Q: What should I do if I miss a dose of Trazodone?

A: If you miss a dose of Trazodone, what you should do depends on when your next dose is scheduled. If it’s for insomnia and you remember it much later in the night, it’s generally best to skip the missed dose to avoid excessive drowsiness the next morning. If it’s for depression and you remember it within a few hours of the missed dose, you can take it. However, if it’s almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one. Consult your healthcare provider or pharmacist for specific advice based on your individual regimen.

Q: Is Trazodone safe for long-term use?

A: Trazodone can be used long-term under the supervision of a healthcare provider. For conditions like major depressive disorder, long-term treatment is often necessary to prevent relapse. For insomnia, while it’s generally recommended to use the lowest effective dose for the shortest necessary duration, some individuals may benefit from long-term use, particularly if their insomnia is chronic or associated with other conditions. Regular follow-ups with your doctor are important to monitor its effectiveness, manage any side effects, and ensure that the benefits continue to outweigh any potential risks associated with prolonged use.

Q: How is Trazodone different from other antidepressants?

A: Trazodone differs from other common antidepressant classes like SSRIs (Selective Serotonin Reuptake Inhibitors) and SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors) primarily in its mechanism of action and its prominent sedative properties. While SSRIs and SNRIs primarily work by inhibiting the reuptake of serotonin (and norepinephrine for SNRIs), Trazodone is a serotonin antagonist and reuptake inhibitor (SARI). This means it not only weakly inhibits serotonin reuptake but also potently blocks specific serotonin receptors (5-HT2A and 5-HT2C), as well as alpha-1 adrenergic and histamine H1 receptors. This unique receptor blockade contributes to its distinct sedative and anxiolytic effects, making it particularly useful for insomnia and anxiety, which are less pronounced or even opposite (activating) in many other antidepressants.